Endoscopy 2006; 38(5): 483-487
DOI: 10.1055/s-2006-924999
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Safety and Efficacy of Endoscopic Balloon Dilation for Treatment of Crohn’s Disease Strictures

A.  Ferlitsch1 , W.  Reinisch1 , A.  Püspök1 , C.  Dejaco1 , M.  Schillinger2 , R.  Schöfl1 , R.  Pötzi1 , A.  Gangl1 , H.  Vogelsang1
  • 1Dept. of Internal Medicine IV, Division of Gastroenterology and Hepatology
  • 2Dept. of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria
Further Information

Publication History

Submitted 25 November 2004

Accepted after revision 5 July 2005

Publication Date:
09 May 2006 (online)

Preview

Background and Study Aims: Strictures are a substantial cause of morbidity in patients with Crohn’s disease. Endoscopic balloon dilation is a therapeutic option in limited strictures to avoid intestinal surgery, although there have been few reports regarding the long-term outcome.
Patients and Methods: Balloon dilation was scheduled for 46 patients (26 women, 20 men; median age 34) with Crohn’s-associated symptomatic and radiographically confirmed intestinal stenosis. The study plan envisaged up to four consecutive treatments within the first 2 months until relief of symptoms, and thereafter dilations depending on clinical requirements.
Results: Dilation was not possible in seven of the 46 patients (15 %), due to technical problems (n = 2), internal fistulas (n = 3), or absence of a stenosis (n = 2). Thirty-nine patients received at least one treatment. The site of obstruction was the ileocolonic anastomosis in 23 of the 39 patients (59 %) and surgically untreated areas in 16 patients (41 %). After the initial dilation series (median 1, interquartile range 1-2), strictures were traversed in 37 of the 39 patients (95 %). During a median follow-up period of 21 months (range 3-98 months), 24 of the 39 patients (62 %) underwent a repeat intervention, including 12 (31 %) with repeat dilation, 11 (28 %) with surgical resection, and one patient who received an intestinal stent. The cumulative percentages of patients without a repeat intervention or surgery at 6, 12, 24, and 36 months were 68 %, 48 %, 36 %, and 31 %, and 97 %, 91 %, 84 % and 75 %, respectively. Two perforations and one case of severe bleeding were seen in the 73 dilation procedures (4 %) performed.
Conclusions: Endoscopic balloon dilation is a safe and effective method that allows surgery to be avoided in approximately 75 % of patients with Crohn’s-associated short intestinal strictures. However, recurrent symptoms frequently make it necessary to repeat the procedure.

References

A. Püspök, M.D.

Division of Gastroenterology and Hepatology

Department of Internal Medicine IV · Medical University of Vienna · Währinger Gürtel 18-20 · 1090 Vienna · Austria

Fax: +43-1-40400-4735·

Email: andreas.puespoek@meduniwien.ac.at